Literature DB >> 4557535

The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.

J R Ryan, A Jain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4557535     DOI: 10.1002/j.1552-4604.1972.tb00054.x

Source DB:  PubMed          Journal:  J Clin Pharmacol New Drugs        ISSN: 0021-9754


× No keyword cloud information.
  8 in total

1.  Treatment of hyperlipoproteinaemia type II A with a new anion exchange resin secholex.

Authors:  A Gustafson; A Lanner
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 2.  Lipid lowering drugs and hyperlipidaemia.

Authors:  R I Levy; B M Rifking
Journal:  Drugs       Date:  1973       Impact factor: 9.546

3.  Effect of colestipol, a new bile acid sequestrant, on the absorption of phenprocoumon in man.

Authors:  C Harvengt; J P Desager
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

4.  Effect of colestipol on sterol metabolism in the rat.

Authors:  M Takahashi; A N Sarwal; R F Raicht; B I Cohen
Journal:  Lipids       Date:  1980-06       Impact factor: 1.880

5.  Effects of colestipol hydrochloride and neomycin sulfate on cholesterol turnover in the rat.

Authors:  W A Phillips; G L Elfring
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

6.  The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble; R B Dell
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

Review 7.  Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

Review 8.  Role of colesevelam in combination lipid-lowering therapy.

Authors:  Michael R Jones; Oliseyenum M Nwose
Journal:  Am J Cardiovasc Drugs       Date:  2013-10       Impact factor: 3.571

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.